BAL PHARMA Fact Sheet, BAL PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA Fact Sheet    (BPHR)


Act Now: Once-in-a-Century Opportunity


Here is the latest financial fact sheet of BAL PHARMA. For more details, see the BAL PHARMA quarterly results and BAL PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

BAL PHARMA Price History

Price Rs 100.0
Mkt Cap Rs m 1,482
Vol '000 5.5
P/E X 52.4
P/CF X 10.4
EPS (TTM) Rs 1.9
% ch % 2.2
No. of shares m 14.82
% ch week % -0.5
% ch 1-mth % 2.7
% ch 12-mth % 82.6
52 week H/L Rs 138.0/50.1
(As on Dec 6, 2021 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BAL PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
BAL PHARMA EQUITY SHARE DATA
High Rs1231281097973 
Low Rs8175632429 
Sales per share (Unadj.) Rs157.3146.2158.8120.7169.0 
Earnings per share (Unadj.) Rs-0.30.31.5-9.13.2 
Diluted earnings per shareRs-0.30.31.5-8.73.2 
Cash flow per share (Unadj.) Rs4.35.05.9-3.79.6 
Dividends per share (Unadj.) Rs1.001.001.0001.00 
Adj. dividends per shareRs0.960.960.960.001.00 
Avg Dividend yield %1.01.01.202.0 
Book value per share (Unadj.) Rs44.145.947.037.035.5 
Adj. book value per shareRs42.143.845.035.435.5 
Shares outstanding (eoy) m14.1714.1714.1714.1714.82 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.60.70.50.40.3 
Avg P/E ratio x-365.1382.556.5-5.616.0 
P/CF ratio (eoy) x23.820.214.6-13.95.3 
Price / Book Value ratio x2.32.21.81.41.4 
Dividend payout %-357.9376.965.8031.5 
Avg Mkt Cap Rs m1,4481,4401,217727753 
No. of employees `000NANANANANA 
Total wages/salary Rs m454522503504419 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BAL PHARMA INCOME DATA
Net Sales Rs m2,2292,0712,2501,7112,505 
Other income Rs m3017101911 
Total revenues Rs m2,2592,0882,2601,7292,517 
Gross profit Rs m14817317750246 
Depreciation Rs m6568627795 
Interest Rs m8594127127122 
Profit before tax Rs m2929-2-13541 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3325-24-6-6 
Profit after tax Rs m-4422-12947 
Gross profit margin %6.68.47.92.99.8 
Effective tax rate %113.886.91,166.04.7-14.9 
Net profit margin %-0.20.21.0-7.51.9 
BAL PHARMA BALANCE SHEET DATA
Current assets Rs m1,6461,8481,8301,5741,641 
Current liabilities Rs m1,4321,5441,6321,5951,525 
Net working cap to sales %9.614.78.8-1.24.6 
Current ratio x1.11.21.11.01.1 
Inventory Days Days12771511 
Debtors Days Days1011131051,058979 
Net fixed assets Rs m688754783810759 
Share capital Rs m142142142142148 
"Free" reserves Rs m483508525383378 
Net worth Rs m624650666524526 
Long term debt Rs m178347288231239 
Total assets Rs m2,3332,6022,6132,3842,401 
Interest coverage x1.31.31.0-0.11.3 
Debt to equity ratio x0.30.50.40.40.5 
Sales to assets ratio x1.00.80.90.71.0 
Return on assets %3.53.85.7-0.17.0 
Return on equity %-0.60.63.2-24.69.0 
Return on capital %14.212.313.1-1.121.2 
Exports to sales %51.847.756.260.560.0 
Imports to sales %26.119.916.115.622.7 
Exports (fob) Rs m1,1549871,2661,0351,504 
Imports (cif) Rs m582412362266568 
Fx inflow Rs m1,1549871,2661,0351,504 
Fx outflow Rs m605432390292586 
Net fx Rs m550556875742918 
BAL PHARMA CASH FLOW
From Operations Rs m 63 6 78 232 218 
From Investments Rs m -80 -36 -80 -47 -50 
From Financial Activity Rs m -59 35 0 -200 -166 
Net Cashflow Rs m -76 5 -3 -16 2 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 46.9%
Institution 0.2%
Non-Institution 53.0%
Total 100.0%
Free Float 53.1%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF #21&22 Bommasandra Industrial Area, Hosur Road, Bengaluru - 560099
E-MAIL info@bglindia.com WEB www.bharatgears.com
TEL 080-22354057/22354058 FAX
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT TSR Darashaw Consultants Pvt Ltd., C-101 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli West
YEAR OF INC: 1987 BSE CODE: 524824 FV (Rs): 10 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SYNGENE INTERNATIONAL  

Compare BAL PHARMA With:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SYNGENE INTERNATIONAL  




Today's Market

5 Reasons Why Sensex Slumped 949 Points Today(Closing)

Indian share markets witnessed huge selling pressure today and ended deep in the red.

Views on news

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BAL PHARMA

  • Track your investment in BAL PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BAL PHARMA

BAL PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE BAL PHARMA WITH

MARKET STATS